Source: International Congress 2016 – Pulmonary drug delivery
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Gerald Smaldone (Stony Brook, United States of America), Gerald Smaldone, Ashwin Gowda, Rohinton Toddywala. Novel jet nebulizer/holding chamber for drug delivery to the deep lung. Eur Respir J 2016; 48: Suppl. 60, 961

Member's Comments

No comment yet.

Related content which might interest you: First in class, respiratory drug gas & drug vapor delivered in a revolutionary and new portable device Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Patients’ opinion for their inhalation device. An assessment of convenience and use Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Antistatic valved holding chambers do not necessarily offer similar aerosol delivery performance Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013 Importance of inhalation device in asthma and COPD: A consensus using Delphi Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Inhalation technique education and its impact in asthma and COPD Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Dislodgement of endobronchial Zephyr valves: An anatomical perspective Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015 The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Predictors of good inhaler technique in asthma and COPD Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Targeted lung denervation in the healthy sheep model - A potential treatment for COPD Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Asthma management - The role of drug delivery Source: Annual Congress 2005 - Asthma management - important issues Year: 2005 Changes in inhalation therapy after combined assessment of COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 The utility of remote cough monitoring in COPD Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Gold vs GesEPOC: Are they different? Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 Importance of surface cooling during targeted lung denervation for COPD Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Critical steps: An evaluation of critical handling errors with DPI use in Greece Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016